Cerebral amyloid angiopathy

Progress in Molecular Biology and Translational Science

Volumn 107, Issue , 2012, Pages 41-78

  Yamada, Masahito ^a   Naiki, Hironobu ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

Author keywords

Alzheimer's disease; Amyloid fibril; Amyloid protein; Cerebral amyloid angiopathy; Cerebral hemorrhage; Cerebrovascular disorders; Dementia; Keywords; Perivascular drainage pathway; Polymerization

Indexed keywords

EID: 84859571761     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385883-2.00006-0     Document Type: Chapter

References (192)

1. H.V. Vinters, and J.J. Gilbert Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes Stroke 14 1983 924 928 (Pubitemid 14205243)
2. M. Yamada, H. Tsukagoshi, E. Otomo, and M. Hayakawa Cerebral amyloid angiopathy in the aged J Neurol 234 1987 371 376
3. J. Masuda, K. Tanaka, K. Ueda, and T. Omae Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan Stroke 19 1988 205 210 (Pubitemid 18084394)
4. M. Yamada Risk factors for cerebral amyloid angiopathy in the elderly Ann N Y Acad Sci 977 2002 37 44 (Pubitemid 35418135)
5. M. Hirohata, M. Yoshita, C. Ishida, S.I. Ikeda, A. Tamaoka, and S. Kuzuhara Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy Eur J Neurol 17 2010 823 829
6. H. Yamaguchi, T. Yamazaki, C.A. Lemere, M.P. Frosch, and D.J. Selkoe β Amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study Am J Pathol 141 1992 249 259
7. W. Scholz Studien zur Pathologie der Hirgefässe. II. Die drusige Entartung der Hirnarterien und -capillaren Z ges Neurol Psychiat 162 1938 694 715
8. D.R. Thal, E. Ghebremedhin, U. Rub, H. Yamaguchi, K. Del Tredici, and H. Braak Two types of sporadic cerebral amyloid angiopathy J Neuropathol Exp Neurol 61 2002 282 293 (Pubitemid 34212603)
9. G.G. Glenner, and C.W. Wong Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein Biochem Biophys Res Commun 120 1984 885 890 (Pubitemid 14104991)
10. F. Prelli, E. Castano, G.G. Glenner, and B. Frangione Differences between vascular and plaque core amyloid in Alzheimer's disease J Neurochem 51 1988 648 651
11. N. Suzuki, T. Iwatsubo, A. Odaka, Y. Ishibashi, C. Kitada, and Y. Ihara High tissue content of soluble β 1-40 is linked to cerebral amyloid angiopathy Am J Pathol 145 1994 452 460 (Pubitemid 24245845)
12. Y. Shinkai, M. Yoshimura, Y. Ito, A. Odaka, N. Suzuki, and K. Yanagisawa Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels Ann Neurol 38 1995 421 428
13. Y. Namba, M. Tomonaga, H. Kawasaki, E. Otomo, and K. Ikeda Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease Brain Res 541 1991 163 166
14. H.V. Vinters, G.S. Nishimura, D.L. Secor, and W.M. Pardridge Immunoreactive A4 and γ-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease Am J Pathol 137 1990 233 240 (Pubitemid 20232983)
15. T.I. Mandybur Cerebral amyloid angiopathy: the vascular pathology and complications J Neuropathol Exp Neurol 45 1986 79 90 (Pubitemid 16189845)
16. J.P. Vonsattel, R.H. Myers, E.T. Hedley-Whyte, A.H. Ropper, E.D. Bird, and E.P. Richardson Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study Ann Neurol 30 1991 637 649
17. A. Maeda, M. Yamada, Y. Itoh, E. Otomo, M. Hayakawa, and T. Miyatake Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy Stroke 24 1993 1857 1864 (Pubitemid 23352716)
18. Y. Itoh, M. Yamada, M. Hayakawa, E. Otomo, and T. Miyatake Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly J Neurol Sci 116 1993 135 141 (Pubitemid 23176848)
19. F. Gray, F. Dubas, E. Roullet, and R. Escourolle Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy Ann Neurol 18 1985 54 59 (Pubitemid 15025414)
20. V. Soontornniyomkij, M.D. Lynch, S. Mermash, J. Pomakian, H. Badkoobehi, and R. Clare Cerebral microinfarcts associated with severe cerebral β-amyloid angiopathy Brain Pathol 20 2010 459 467
21. M. Yamada, Y. Itoh, M. Shintaku, J. Kawamura, O. Jensson, and L. Thorsteinsson Immune reactions associated with cerebral amyloid angiopathy Stroke 27 1996 1155 1162 (Pubitemid 26226947)
22. U. Oh, R. Gupta, J.W. Krakauer, A.G. Khandji, S.S. Chin, and M.S. Elkind Reversible leukoencephalopathy associated with cerebral amyloid angiopathy Neurology 62 2004 494 497 (Pubitemid 38200871)
23. J.A. Eng, M.P. Frosch, K. Choi, G.W. Rebeck, and S.M. Greenberg Clinical manifestations of cerebral amyloid angiopathy-related inflammation Ann Neurol 55 2004 250 256 (Pubitemid 38167002)
24. N.J. Scolding, F. Joseph, P.A. Kirby, I. Mazanti, F. Gray, and J. Mikol Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy Brain 128 2005 500 515 (Pubitemid 40380186)
25. C. Kinnecom, M.H. Lev, L. Wendell, E.E. Smith, J. Rosand, and M.P. Frosch Course of cerebral amyloid angiopathy-related inflammation Neurology 68 2007 1411 1416 (Pubitemid 46661556)
26. S.M. Greenberg, G.W. Rebeck, J.P. Vonsattel, T. Gomez-Isla, and B.T. Hyman Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy Ann Neurol 38 1995 254 259
27. D.R. Premkumar, D.L. Cohen, P. Hedera, R.P. Friedland, and R.N. Kalaria Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease Am J Pathol 148 1996 2083 2095
28. J.A. Nicoll, C. Burnett, S. Love, D.I. Graham, D. Dewar, and J.W. Ironside High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy Ann Neurol 41 1997 716 721 (Pubitemid 27249176)
29. H.C. O'Donnell, J. Rosand, K.A. Knudsen, K.L. Furie, A.Z. Segal, and R.I. Chiu Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage N Engl J Med 342 2000 240 245 (Pubitemid 30058955)
30. P.D. Leclercq, L.S. Murray, C. Smith, D.I. Graham, J.A. Nicoll, and S.M. Gentleman Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype J Neurol Neurosurg Psychiatry 76 2005 229 233 (Pubitemid 40143713)
31. M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, and M. Matsushita Association of presenilin-1 polymorphism with cerebral amyloid angiopathy in the elderly Stroke 28 1997 2219 2221 (Pubitemid 27497926)
32. M. Yamada, N. Sodeyama, Y. Itoh, N. Suematsu, E. Otomo, and M. Matsushita Association of α1-antichymotrypsin polymorphism with cerebral amyloid angiopathy Ann Neurol 44 1998 129 131 (Pubitemid 28323663)
33. M. Yamada, N. Sodeyama, Y. Itoh, A. Takahashi, E. Otomo, and M. Matsushita Association of neprilysin polymorphism with cerebral amyloid angiopathy J Neurol Neurosurg Psychiatry 74 2003 749 751 (Pubitemid 36628287)
34. M. Yamada Cerebral amyloid angiopathy and gene polymorphisms J Neurol Sci 226 2004 41 44 (Pubitemid 39505403)
35. T. Hamaguchi, S. Okino, N. Sodeyama, Y. Itoh, A. Takahashi, and E. Otomo Association of a polymorphism of the transforming growth factor-β1 gene with cerebral amyloid angiopathy J Neurol Neurosurg Psychiatry 76 2005 696 699 (Pubitemid 40569681)
36. M. Christoforidis, R. Schober, and K. Krohn Genetic-morphologic association study: association between the low density lipoprotein-receptor related protein (LRP) and cerebral amyloid angiopathy Neuropathol Appl Neurobiol 31 2005 11 19 (Pubitemid 40222821)
37. R. Peila, B. Yucesoy, L.R. White, V. Johnson, M.L. Kashon, and K. Wu A TGF-β1 polymorphism association with dementia and neuropathologies: the HAAS Neurobiol Aging 28 2007 1367 1373 (Pubitemid 47081228)
38. S. Domingues-Montanari, M. Hernandez-Guillamon, I. Fernandez-Cadenas, M. Mendioroz, M. Boada, and J. Munuera ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy Neurobiol Aging 32 2010 551.e13 551.e22
39. D.R. Thal, A. Papassotiropoulos, T.C. Saido, W.S. Griffin, R.E. Mrak, and H. Kolsch Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease Acta Neuropathol 120 2010 169 183
40. H. Arima, C. Tzourio, C. Anderson, M. Woodward, M.G. Bousser, and S. MacMahon Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial Stroke 41 2010 394 396
41. M.O. McCarron, and J.A. Nicoll Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage Lancet Neurol 3 2004 484 492 (Pubitemid 38903099)
42. J. Rosand, E.M. Hylek, H.C. O'Donnell, and S.M. Greenberg Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study Neurology 55 2000 947 951
43. M.W. Vernooij, M.D. Haag, A. van der Lugt, A. Hofman, G.P. Krestin, and B.H. Stricker Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study Arch Neurol 66 2009 714 720
44. M. Yamada, Y. Itoh, E. Otomo, M. Hayakawa, and T. Miyatake Subarachnoid haemorrhage in the elderly: a necropsy study of the association with cerebral amyloid angiopathy J Neurol Neurosurg Psychiatry 56 1993 543 547 (Pubitemid 23171788)
45. T. Ohshima, T. Endo, H. Nukui, S. Ikeda, D. Allsop, and T. Onaya Cerebral amyloid angiopathy as a cause of subarachnoid hemorrhage Stroke 21 1990 480 483 (Pubitemid 20089800)
46. S.M. Greenberg, J.P. Vonsattel, J.W. Stakes, M. Gruber, and S.P. Finklestein The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage Neurology 43 1993 2073 2079 (Pubitemid 23318883)
47. A. Izenberg, R.I. Aviv, B.M. Demaerschalk, D.W. Dodick, J. Hopyan, and S.E. Black Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage Stroke 40 2009 3725 3729
48. M. Yamada, Y. Itoh, N. Suematsu, E. Otomo, and M. Matsushita Vascular variant of Alzheimer's disease characterized by severe plaque-like β protein angiopathy Dement Geriatr Cogn Disord 8 1997 163 168 (Pubitemid 27183221)
49. S.M. Greenberg, M.E. Gurol, J. Rosand, and E.E. Smith Amyloid angiopathy-related vascular cognitive impairment Stroke 35 2004 2616 2619 (Pubitemid 39458351)
50. S.M. Greenberg, S.P. Finklestein, and P.W. Schaefer Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI Neurology 46 1996 1751 1754 (Pubitemid 26185809)
51. H.C. Koennecke Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications Neurology 66 2006 165 171
52. S.H. Lee, S.M. Kim, N. Kim, B.W. Yoon, and J.K. Roh Cortico-subcortical distribution of microbleeds is different between hypertension and cerebral amyloid angiopathy J Neurol Sci 258 2007 111 114 (Pubitemid 46874485)
53. Y. Nakata-Kudo, T. Mizuno, K. Yamada, K. Shiga, K. Yoshikawa, and S. Mori Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease Dement Geriatr Cogn Disord 22 2006 8 14
54. J. Rosand, A. Muzikansky, A. Kumar, J.J. Wisco, E.E. Smith, and R.A. Betensky Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy Ann Neurol 58 2005 459 462 (Pubitemid 41266633)
55. H.H. Feldman, L.F. Maia, I.R. Mackenzie, B.B. Forster, J. Martzke, and A. Woolfenden Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease Stroke 39 2008 2894 2897
56. S. Kumar, R.P. Goddeau Jr., M.H. Selim, A. Thomas, G. Schlaug, and A. Alhazzani Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies Neurology 74 2010 893 899
57. M.W. Vernooij, M.A. Ikram, A. Hofman, G.P. Krestin, M.M. Breteler, and A. van der Lugt Superficial siderosis in the general population Neurology 73 2009 202 205
58. E.E. Smith, M.E. Gurol, J.A. Eng, C.R. Engel, T.N. Nguyen, and J. Rosand White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage Neurology 63 2004 1606 1612 (Pubitemid 39507576)
59. Y.W. Chen, M.E. Gurol, J. Rosand, A. Viswanathan, S.M. Rakich, and T.R. Groover Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy Neurology 67 2006 83 87 (Pubitemid 44305466)
60. O.C. Suter, T. Sunthorn, R. Kraftsik, J. Straubel, P. Darekar, and K. Khalili Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease Stroke 33 2002 1986 1992 (Pubitemid 34840055)
61. W.T. Kimberly, A. Gilson, N.S. Rost, J. Rosand, A. Viswanathan, and E.E. Smith Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy Neurology 72 2009 1230 1235
62. Y.A. Chung, J.H. O, J.Y. Kim, K.J. Kim, and K.J. Ahn Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT J Nucl Med 50 2009 1969 1974
63. K.A. Johnson, M. Gregas, J.A. Becker, C. Kinnecom, D.H. Salat, and E.K. Moran Imaging of amyloid burden and distribution in cerebral amyloid angiopathy Ann Neurol 62 2007 229 234 (Pubitemid 47525398)
64. J.V. Ly, G.A. Donnan, V.L. Villemagne, J.A. Zavala, H. Ma, and G. O'Keefe 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage Neurology 74 2010 487 493
65. B.J. Bacskai, M.P. Frosch, S.H. Freeman, S.B. Raymond, J.C. Augustinack, and K.A. Johnson Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report Arch Neurol 64 2007 431 434 (Pubitemid 46425701)
66. M.M. Verbeek, B.P. Kremer, M.O. Rikkert, P.H. Van Domburg, M.E. Skehan, and S.M. Greenberg Cerebrospinal fluid amyloid β (40) is decreased in cerebral amyloid angiopathy Ann Neurol 66 2009 245 249
67. M.E. Gurol, M.C. Irizarry, E.E. Smith, S. Raju, R. Diaz-Arrastia, and T. Bottiglieri Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy Neurology 66 2006 23 29 (Pubitemid 43739586)
68. K.A. Knudsen, J. Rosand, D. Karluk, and S.M. Greenberg Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria Neurology 56 2001 537 539 (Pubitemid 32172884)
69. G.M. Greene, J.C. Godersky, J. Biller, M.N. Hart, and H.P. Adams Jr. Surgical experience with cerebral amyloid angiopathy Stroke 21 1990 1545 1549
70. A. Izumihara, M. Suzuki, and T. Ishihara Recurrence and extension of lobar hemorrhage related to cerebral amyloid angiopathy: multivariate analysis of clinical risk factors Surg Neurol 64 2005 160 164 discussion 164 (Pubitemid 41044144)
71. E. Levy, M.D. Carman, I.J. Fernandez-Madrid, M.D. Power, I. Lieberburg, and S.G. van Duinen Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type Science 248 1990 1124 1126
72. M. Bornebroek, C. De Jonghe, J. Haan, S. Kumar-Singh, S. Younkin, and R. Roos Hereditary cerebral hemorrhage with amyloidosis Dutch type (AβPP 693): decreased plasma amyloid-β 42 concentration Neurobiol Dis 14 2003 619 623 (Pubitemid 37543538)
73. O. Bugiani, G. Giaccone, G. Rossi, M. Mangieri, R. Capobianco, and M. Morbin Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP Arch Neurol 67 2010 987 995
74. C. Nilsberth, A. Westlind-Danielsson, C.B. Eckman, M.M. Condron, K. Axelman, and C. Forsell The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat Neurosci 4 2001 887 893 (Pubitemid 32801591)
75. L. Hendriks, C.M. van Duijn, P. Cras, M. Cruts, W. Van Hul, and F. van Harskamp Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene Nat Genet 1 1992 218 221
76. P. Cras, F. van Harskamp, L. Hendriks, C. Ceuterick, C.M. van Duijn, and S.Z. Stefanko Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala->Gly mutation Acta Neuropathol 96 1998 253 260 (Pubitemid 28419843)
77. T.J. Grabowski, H.S. Cho, J.P. Vonsattel, G.W. Rebeck, and S.M. Greenberg Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy Ann Neurol 49 2001 697 705 (Pubitemid 32530235)
78. S.M. Greenberg, T. Grabowski, M.E. Gurol, M.E. Skehan, R.N. Nandigam, and J.A. Becker Detection of isolated cerebrovascular β-amyloid with Pittsburgh compound B Ann Neurol 64 2008 587 591
79. L. Obici, A. Demarchi, G. de Rosa, V. Bellotti, S. Marciano, and S. Donadei A novel AβPP mutation exclusively associated with cerebral amyloid angiopathy Ann Neurol 58 2005 639 644 (Pubitemid 41377231)
80. G. Rossi, G. Giaccone, R. Maletta, M. Morbin, R. Capobianco, and M. Mangieri A family with Alzheimer disease and strokes associated with A713T mutation of the APP gene Neurology 63 2004 910 912 (Pubitemid 39297659)
81. A. Rovelet-Lecrux, D. Hannequin, G. Raux, N. Le Meur, A. Laquerriere, and A. Vital APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy Nat Genet 38 2006 24 26 (Pubitemid 43011878)
82. D. Nochlin, T.D. Bird, E.J. Nemens, M.J. Ball, and S.M. Sumi Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I) Ann Neurol 43 1998 131 135 (Pubitemid 28124661)
83. B. Dermaut, S. Kumar-Singh, C. De Jonghe, M. Cruts, A. Lofgren, and U. Lubke Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation Brain 124 2001 2383 2392 (Pubitemid 33134928)
84. D.M. Mann, S.M. Pickering-Brown, A. Takeuchi, and T. Iwatsubo Amyloid angiopathy and variability in amyloid β deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease Am J Pathol 158 2001 2165 2175 (Pubitemid 32545202)
85. M.G. Belza, and H. Urich Cerebral amyloid angiopathy in Down's syndrome Clin Neuropathol 5 1986 257 260 (Pubitemid 17216117)
86. G. Gudmundsson, J. Hallgrimsson, T.A. Jonasson, and O. Bjarnason Hereditary cerebral haemorrhage with amyloidosis Brain 95 1972 387 404
87. E. Levy, C. Lopez-Otin, J. Ghiso, D. Geltner, and B. Frangione Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases J Exp Med 169 1989 1771 1778 (Pubitemid 19126832)
88. A. Grubb, O. Jensson, G. Gudmundsson, A. Arnason, H. Lofberg, and J. Malm Abnormal metabolism of γ-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis N Engl J Med 311 1984 1547 1549 (Pubitemid 15223255)
89. R. Janowski, M. Kozak, E. Jankowska, Z. Grzonka, A. Grubb, and M. Abrahamson Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping Nat Struct Biol 8 2001 316 320 (Pubitemid 32275015)
90. M. Bjarnadottir, C. Nilsson, V. Lindstrom, A. Westman, P. Davidsson, and F. Thormodsson The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids Amyloid 8 2001 1 10 (Pubitemid 32210175)
91. A. Palsdottir, A.O. Snorradottir, and L. Thorsteinsson Hereditary cystatin C amyloid angiopathy: genetic, clinical, and pathological aspects Brain Pathol 16 2006 55 59
92. B. Ghetti, P. Piccardo, M.G. Spillantini, Y. Ichimiya, M. Porro, and F. Perini Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP Proc Natl Acad Sci USA 93 1996 744 748 (Pubitemid 26041161)
93. T. Revesz, J.L. Holton, T. Lashley, G. Plant, B. Frangione, and A. Rostagno Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies Acta Neuropathol 118 2009 115 130
94. C. Jansen, P. Parchi, S. Capellari, A.J. Vermeij, P. Corrado, and F. Baas Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP Acta Neuropathol 119 2010 189 197
95. G.T. Plant, T. Revesz, R.O. Barnard, A.E. Harding, and P.C. Gautier-Smith Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation Brain 113 Pt. 3 1990 721 747 (Pubitemid 20222328)
96. R. Vidal, B. Frangione, A. Rostagno, S. Mead, T. Revesz, and G. Plant A stop-codon mutation in the BRI gene associated with familial British dementia Nature 399 1999 776 781 (Pubitemid 29293172)
97. R. Vidal, T. Revesz, A. Rostagno, E. Kim, J.L. Holton, and T. Bek A decamer duplication in the 3′ region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred Proc Natl Acad Sci USA 97 2000 4920 4925 (Pubitemid 30238658)
98. T. Yamashita, Y. Ando, M. Ueda, M. Nakamura, S. Okamoto, and M.E. Zeledon Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy Neurology 70 2008 123 128
99. S. Kiuru, O. Salonen, and M. Haltia Gelsolin-related spinal and cerebral amyloid angiopathy Ann Neurol 45 1999 305 311 (Pubitemid 29120034)
100. R. Schroder, M. Deckert, and R.P. Linke Novel isolated cerebral ALlambda amyloid angiopathy with widespread subcortical distribution and leukoencephalopathy due to atypical monoclonal plasma cell proliferation, and terminal systemic gammopathy J Neuropathol Exp Neurol 68 2009 286 299
101. H.M. Wisniewski, and J. Wegiel β-Amyloid formation by myocytes of leptomeningeal vessels Acta Neuropathol 87 1994 233 241
102. R.O. Weller, A. Massey, T.A. Newman, M. Hutchings, Y.M. Kuo, and A.E. Roher Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease Am J Pathol 153 1998 725 733 (Pubitemid 28419027)
103. R.O. Weller, M. Subash, S.D. Preston, I. Mazanti, and R.O. Carare Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease Brain Pathol 18 2008 253 266 (Pubitemid 351430402)
104. M.C. Herzig, D.T. Winkler, P. Burgermeister, M. Pfeifer, E. Kohler, and S.D. Schmidt Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis Nat Neurosci 7 2004 954 960 (Pubitemid 39129504)
105. M.C. Herzig, W.E. Van Nostrand, and M. Jucker Mechanism of cerebral β-amyloid angiopathy: murine and cellular models Brain Pathol 16 2006 40 54
106. J.S. Miners, Z. Van Helmond, K. Chalmers, G. Wilcock, S. Love, and P.G. Kehoe Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy J Neuropathol Exp Neurol 65 2006 1012 1021 (Pubitemid 44521802)
107. M.A. Leissring, W. Farris, A.Y. Chang, D.M. Walsh, X. Wu, and X. Sun Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death Neuron 40 2003 1087 1093 (Pubitemid 38032786)
108. R.D. Bell, A.P. Sagare, A.E. Friedman, G.S. Bedi, D.M. Holtzman, and R. Deane Transport pathways for clearance of human Alzheimer's amyloid β-peptide and apolipoproteins E and J in the mouse central nervous system J Cereb Blood Flow Metab 27 2007 909 918 (Pubitemid 46659038)
109. M. Shibata, S. Yamada, S.R. Kumar, M. Calero, J. Bading, and B. Frangione Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J Clin Invest 106 2000 1489 1499 (Pubitemid 32038587)
110. N.J. Abbott Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology Neurochem Int 45 2004 545 552 (Pubitemid 38739482)
111. I. Szentistvanyi, C.S. Patlak, R.A. Ellis, and H.F. Cserr Drainage of interstitial fluid from different regions of rat brain Am J Physiol 246 1984 F835 F844
112. R.O. Carare, M. Bernardes-Silva, T.A. Newman, A.M. Page, J.A. Nicoll, and V.H. Perry Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology Neuropathol Appl Neurobiol 34 2008 131 144 (Pubitemid 351327967)
113. D. Schley, R. Carare-Nnadi, C.P. Please, V.H. Perry, and R.O. Weller Mechanisms to explain the reverse perivascular transport of solutes out of the brain J Theor Biol 238 2006 962 974 (Pubitemid 43175842)
114. D.M. Wilcock, A. Rojiani, A. Rosenthal, S. Subbarao, M.J. Freeman, and M.N. Gordon Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage J Neuroinflammation 1 2004 24
115. M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller, and M. Staufenbiel Cerebral hemorrhage after passive anti-Aβ immunotherapy Science 298 2002 1379 (Pubitemid 35346131)
116. D. Boche, E. Zotova, R.O. Weller, S. Love, J.W. Neal, and R.M. Pickering Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brain Brain 131 2008 3299 3310
117. J.D. Harper, and P.T. Lansbury Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu Rev Biochem 66 1997 385 407 (Pubitemid 27274662)
118. H. Naiki, and Y. Nagai Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins J Biochem 146 2009 751 756
119. R. Roychaudhuri, M. Yang, M.M. Hoshi, and D.B. Teplow Amyloid β-protein assembly and Alzheimer disease J Biol Chem 284 2009 4749 4753
120. C.G. Glabe Structural classification of toxic amyloid oligomers J Biol Chem 283 2008 29639 29643
121. J.W. Wu, L. Breydo, J.M. Isas, J. Lee, Y.G. Kuznetsov, and R. Langen Fibrillar oligomers nucleate the oligomerization of monomeric amyloid β but do not seed fibril formation J Biol Chem 285 2010 6071 6079
122. F. Prelli, E. Levy, S.G. van Duinen, G.T. Bots, W. Luyendijk, and B. Frangione Expression of a normal and variant Alzheimer's β-protein gene in amyloid of hereditary cerebral hemorrhage, Dutch type: DNA and protein diagnostic assays Biochem Biophys Res Commun 170 1990 301 307 (Pubitemid 20249419)
123. Y. Tomidokoro, A. Rostagno, T.A. Neubert, Y. Lu, G.W. Rebeck, and B. Frangione Iowa variant of familial Alzheimer's disease: accumulation of posttranslationally modified AβD23N in parenchymal and cerebrovascular amyloid deposits Am J Pathol 176 2010 1841 1854
124. L. Miravalle, T. Tokuda, R. Chiarle, G. Giaccone, O. Bugiani, and F. Tagliavini Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells J Biol Chem 275 2000 27110 27116
125. W.E. Van Nostrand, J.P. Melchor, H.S. Cho, S.M. Greenberg, and G.W. Rebeck Pathogenic effects of D23N Iowa mutant amyloid β-protein J Biol Chem 276 2001 32860 32866
126. J. Ghiso, and B. Frangione Amyloidosis and Alzheimer's disease Adv Drug Deliv Rev 54 2002 1539 1551 (Pubitemid 35346828)
127. T. Lashley, J.L. Holton, M.M. Verbeek, A. Rostagno, M. Bojsen-Moller, and G. David Molecular chaperones, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study Neuropathol Appl Neurobiol 32 2006 492 504 (Pubitemid 44401511)
128. M.M. Verbeek, I. Otte-Holler, R. Veerhuis, D.J. Ruiter, and R.M. De Waal Distribution of A β-associated proteins in cerebrovascular amyloid of Alzheimer's disease Acta Neuropathol 96 1998 628 636 (Pubitemid 28517657)
129. M. Hart, L. Li, T. Tokunaga, J.R. Lindsey, J.R. Hassell, and A.D. Snow Overproduction of perlecan core protein in cultured cells and transgenic mice J Pathol 194 2001 262 269
130. G.M. Castillo, W. Lukito, E. Peskind, M. Raskind, D.A. Kirschner, and A.G. Yee Laminin inhibition of β-amyloid protein (Aβ) fibrillogenesis and identification of an Aβ binding site localized to the globular domain repeats on the laminin a chain J Neurosci Res 62 2000 451 462
131. G.P. Gorbenko, and P.K. Kinnunen The role of lipid-protein interactions in amyloid-type protein fibril formation Chem Phys Lipids 141 2006 72 82 (Pubitemid 43728804)
132. K. Yanagisawa Role of gangliosides in Alzheimer's disease Biochim Biophys Acta 1768 2007 1943 1951 (Pubitemid 47125848)
133. K. Matsuzaki Physicochemical interactions of amyloid β-peptide with lipid bilayers Biochim Biophys Acta 1768 2007 1935 1942 (Pubitemid 47135568)
134. M.R. Wilson, J.J. Yerbury, and S. Poon Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity Mol Biosyst 4 2008 42 52 (Pubitemid 350261753)
135. J.J. Yerbury, S. Poon, S. Meehan, B. Thompson, J.R. Kumita, and C.M. Dobson The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures FASEB J 21 2007 2312 2322 (Pubitemid 47230661)
136. J.J. Yerbury, J.R. Kumita, S. Meehan, C.M. Dobson, and M.R. Wilson α2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species J Biol Chem 284 2009 4246-4254
137. J.S. Miners, S. Baig, J. Palmer, L.E. Palmer, P.G. Kehoe, and S. Love Aβ-degrading enzymes in Alzheimer's disease Brain Pathol 18 2008 240 252
138. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180 (Pubitemid 33030186)
139. Y.J. Wang, H.D. Zhou, and X.F. Zhou Clearance of amyloid-β in Alzheimer's disease: progress, problems and perspectives Drug Discov Today 11 2006 931 938
140. E.R. Vardy, A.J. Catto, and N.M. Hooper Proteolytic mechanisms in amyloid-β metabolism: therapeutic implications for Alzheimer's disease Trends Mol Med 11 2005 464 472 (Pubitemid 41415726)
141. L. Morelli, R.E. Llovera, I. Mathov, L.F. Lue, B. Frangione, and J. Ghiso Insulin-degrading enzyme in brain microvessels: proteolysis of amyloid β vasculotropic variants and reduced activity in cerebral amyloid angiopathy J Biol Chem 279 2004 56004 56013 (Pubitemid 40066608)
142. S. Tsubuki, Y. Takaki, and T.C. Saido Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation Lancet 361 2003 1957 1958 (Pubitemid 36694587)
143. T. Revesz, J. Ghiso, T. Lashley, G. Plant, A. Rostagno, and B. Frangione Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view J Neuropathol Exp Neurol 62 2003 885 898 (Pubitemid 37159029)
144. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 2001 741 766 (Pubitemid 32267077)
145. S. Nagasawa, H. Handa, A. Okumura, Y. Naruo, K. Moritake, and K. Hayashi Mechanical properties of human cerebral arteries. Part 1: effects of age and vascular smooth muscle activation Surg Neurol 12 1979 297 304 (Pubitemid 10197793)
146. T.G. Beach, P.E. Potter, Y.M. Kuo, M.R. Emmerling, R.A. Durham, and S.D. Webster Cholinergic deafferentation of the rabbit cortex: a new animal model of Aβ deposition Neurosci Lett 283 2000 9 12 (Pubitemid 30145484)
147. T.G. Beach, Y.M. Kuo, K. Spiegel, M.R. Emmerling, L.I. Sue, and K. Kokjohn The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease J Neuropathol Exp Neurol 59 2000 308 313 (Pubitemid 30183698)
148. R.O. Weller, and J.A. Nicoll Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain Neurol Res 25 2003 611 616 (Pubitemid 37087605)
149. J. Van Dorpe, L. Smeijers, I. Dewachter, D. Nuyens, K. Spittaels, and C. Van Den Haute Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons Am J Pathol 157 2000 1283 1298
150. J. Frackowiak, A. Potempska, H. LeVine, T. Haske, D. Dickson, and B. Mazur-Kolecka Extracellular deposits of Aβ produced in cultures of Alzheimer disease brain vascular smooth muscle cells J Neuropathol Exp Neurol 64 2005 82 90 (Pubitemid 40189482)
151. J.A. Nicoll, M. Yamada, J. Frackowiak, B. Mazur-Kolecka, and R.O. Weller Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement Neurobiol Aging 25 2004 589 597 [discussion 603-604] (Pubitemid 38686478)
152. R. Kisilevsky, J.B. Ancsin, W.A. Szarek, and S. Petanceska Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications Amyloid 14 2007 21 32 (Pubitemid 46491162)
153. E. Farkas, G.I. De Jong, R.A. de Vos, E.N. Jansen Steur, and P.G. Luiten Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease Acta Neuropathol 100 2000 395 402 (Pubitemid 30497009)
154. A. Navarro, E. Del Valle, A. Astudillo, C. Gonzalez del Rey, and J. Tolivia Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral β amyloid deposits Exp Neurol 184 2003 697 704 (Pubitemid 38182798)
155. M.O. McCarron, J.A. Nicoll, J. Stewart, J.W. Ironside, D.M. Mann, and S. Love The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage J Neuropathol Exp Neurol 58 1999 711 718 (Pubitemid 29328500)
156. D.M. Holtzman In vivo effects of ApoE and clusterin on amyloid-β metabolism and neuropathology J Mol Neurosci 23 2004 247 254
157. S.W. Snyder, U.S. Ladror, W.S. Wade, G.T. Wang, L.W. Barrett, and E.D. Matayoshi Amyloid-β aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths Biophys J 67 1994 1216 1228
158. E. McGowan, F. Pickford, J. Kim, L. Onstead, J. Eriksen, and C. Yu Aβ42 is essential for parenchymal and vascular amyloid deposition in mice Neuron 47 2005 191 199 (Pubitemid 41019251)
159. J. Kim, L. Onstead, S. Randle, R. Price, L. Smithson, and C. Zwizinski Aβ40 inhibits amyloid deposition in vivo J Neurosci 27 2007 627 633 (Pubitemid 46143766)
160. M. Citron, T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, and P. Seubert Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production Nature 360 1992 672 674 (Pubitemid 23007680)
161. M. Mullan, F. Crawford, K. Axelman, H. Houlden, L. Lilius, and B. Winblad A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid Nat Genet 1 1992 345 347
162. L. Lannfelt, N. Bogdanovic, H. Appelgren, K. Axelman, L. Lilius, and G. Hansson Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family Neurosci Lett 168 1994 254 256 (Pubitemid 24097370)
163. M.E. Calhoun, P. Burgermeister, A.L. Phinney, M. Stalder, M. Tolnay, and K.H. Wiederhold Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid Proc Natl Acad Sci USA 96 1999 14088 14093
164. L. Morelli, R. Llovera, S.A. Gonzalez, J.L. Affranchino, F. Prelli, and B. Frangione Differential degradation of amyloid β genetic variants associated with hereditary dementia or stroke by insulin-degrading enzyme J Biol Chem 278 2003 23221 23226 (Pubitemid 36830134)
165. O.R. Monro, J.B. Mackic, S. Yamada, M.B. Segal, J. Ghiso, and C. Maurer Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood Neurobiol Aging 23 2002 405 412 (Pubitemid 34312024)
166. M. Citron, D. Westaway, W. Xia, G. Carlson, T. Diehl, and G. Levesque Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice Nat Med 3 1997 67 72 (Pubitemid 27019143)
167. D.R. Borchelt, T. Ratovitski, J. van Lare, M.K. Lee, V. Gonzales, and N.A. Jenkins Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins Neuron 19 1997 939 945 (Pubitemid 27471397)
168. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, and P. Jantzen Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nat Med 4 1998 97 100 (Pubitemid 28133087)
169. N. Yamamoto, Y. Hirabayashi, M. Amari, H. Yamaguchi, G. Romanov, and W.E. Van Nostrand Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides FEBS Lett 579 2005 2185 2190 (Pubitemid 40469690)
170. N. Yamamoto, W.E. Van Nostrand, and K. Yanagisawa Further evidence of local ganglioside-dependent amyloid β-protein assembly in brain Neuroreport 17 2006 1735 1737 (Pubitemid 44621574)
171. N. Yamamoto, K. Hasegawa, K. Matsuzaki, H. Naiki, and K. Yanagisawa Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid β-protein J Neurochem 90 2004 62 69 (Pubitemid 38879162)
172. N. Oikawa, H. Yamaguchi, K. Ogino, T. Taki, K. Yuyama, and N. Yamamoto Gangliosides determine the amyloid pathology of Alzheimer's disease Neuroreport 20 2009 1043 1046
173. W.W. Zhang, H. Lempessi, and Y. Olsson Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells Acta Neuropathol 96 1998 558 563 (Pubitemid 28517648)
174. J.M. Lee, K. Yin, I. Hsin, S. Chen, J.D. Fryer, and D.M. Holtzman Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage J Neurol Sci 229-230 2005 249 254 (Pubitemid 40341590)
175. A. Morinaga, K. Hasegawa, R. Nomura, T. Ookoshi, D. Ozawa, and Y. Goto Critical role of interfaces and agitation on the nucleation of Aβ amyloid fibrils at low concentrations of Aβ monomers Biochim Biophys Acta 1804 2010 986 995
176. S.M. Greenberg, J.A. Eng, M. Ning, E.E. Smith, and J. Rosand Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage Stroke 35 2004 1415 1420 (Pubitemid 38697468)
177. S.M. Greenberg, R.N. Nandigam, P. Delgado, R.A. Betensky, J. Rosand, and A. Viswanathan Microbleeds versus macrobleeds: evidence for distinct entities Stroke 40 2009 2382 2386
178. M.A. Sloan, T.R. Price, C.K. Petito, A.M. Randall, R.E. Solomon, and M.L. Terrin Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience Neurology 45 1995 649 658
179. P. Trouillas, and R. von Kummer Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke Stroke 37 2006 556 561 (Pubitemid 43732026)
180. M. Hernandez-Guillamon, S. Mawhirt, S. Fossati, S. Blais, M. Pares, and A. Penalba Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-β E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells J Biol Chem 285 2010 27144 27158
181. M. Kim, H.J. Bae, J. Lee, L. Kang, S. Lee, and S. Kim APOE epsilon2/epsilon4 polymorphism and cerebral microbleeds on gradient-echo MRI Neurology 65 2005 1474 1475 (Pubitemid 41552785)
182. M.W. Vernooij, A. van der Lugt, M.A. Ikram, P.A. Wielopolski, W.J. Niessen, and A. Hofman Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study Neurology 70 2008 1208 1214 (Pubitemid 351482572)
183. J.A. Ronald, Y. Chen, L. Bernas, H.H. Kitzler, K.A. Rogers, and R.A. Hegele Clinical field-strength MRI of amyloid plaques induced by low-level cholesterol feeding in rabbits Brain 132 2009 1346 1354
184. S. van Rooden, M.L. Maat-Schieman, R.J. Nabuurs, L. van der Weerd, S. van Duijn, and S.G. van Duinen Cerebral amyloidosis: postmortem detection with human 7.0-T MR imaging system Radiology 253 2009 788 796
185. R.D. Bell, and B.V. Zlokovic Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathol 118 2009 103 113
186. M.M. Racke, L.I. Boone, D.L. Hepburn, M. Parsadainian, M.T. Bryan, and D.K. Ness Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid β J Neurosci 25 2005 629 636
187. D.M. Wilcock, P.T. Jantzen, Q. Li, D. Morgan, and M.N. Gordon Amyloid-β vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid Neuroscience 144 2007 950 960 (Pubitemid 46019842)
188. C.M. Prada, M. Garcia-Alloza, R.A. Betensky, S.X. Zhang-Nunes, S.M. Greenberg, and B.J. Bacskai Antibody-mediated clearance of amyloid-β peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging J Neurosci 27 2007 1973 1980
189. S. Schroeter, K. Khan, R. Barbour, M. Doan, M. Chen, and T. Guido Immunotherapy reduces vascular amyloid-β in PDAPP mice J Neurosci 28 2008 6787 6793
190. J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, and L.C. Kirby Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization Neurology 61 2003 46 54 (Pubitemid 36818745)
191. J.A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham, and R.O. Weller Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report Nat Med 9 2003 448 452 (Pubitemid 36460079)
192. S. Salloway, R. Sperling, S. Gilman, N.C. Fox, K. Blennow, and M. Raskind A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease Neurology 73 2009 2061 2070